Aim of this study is to evaluate the effects of the adductor canal block on the early and medium term ( 1 month) rehabilitation compared to the continuous femoral block commonly used in the knee prosthesis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert in adductor canal through tuohy needle (18G, 100mm length) under ultrasound guidance.
Perinervous catheter (stimulong sono- Pajunk, Germany) will be insert between femoral nerve and femoral artery through tuohy needle (18G, 100mm length) under ultrasound guidance.
Spinal anesthesia will be perform at L3-L4 or L4-L5 level. Levobupivacaine 0,5% 12mg will be injected.
Istituto ortopedico Gaetano Pini
Milan, Italy
Up and Go test
Knee functional evaluation at 5th postoperative day. "up and go" test: time need to get up from a chair, walk for 3 meters, and come back to seat down on the chair
Time frame: 5th postoperative day
VAS score
Evaluation of VAS static and VAS dynamic during hospital stay
Time frame: up to POD5
Morphine request
Opioids consumption will be recorded throughout postoperative period
Time frame: up to POD5
Range of motion
Physiotherapist measures the maximum active/passive range of motion
Time frame: 5th postoperative day
Falling risk
Evaluation of falling risk with Berg Balance Scale
Time frame: 5th postoperative day
Quadriceps strength
evaluate muscle strength with an isometric force dynamometer to measure the force produced during a maximum voluntary isometric contraction in a lying position by the knee flex to 90°.
Time frame: 5th postoperative day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Continuous infusion of levobupivacaine 0,125% at 8ml/h rate through perinervous catheter until 5th postoperative day.
Ketorolac 30mg 3 times/day and morphine Patients Control Analgesia (1mg/h, max 4mg/h) administered.